Advertisement

Picture EBD Group Digital Medicine & Medtech Showcase 2021 at BTS2021 651x81
Document › Details

Hofmann, Siegfried / Brors, Peter. (12/5/18). "News: Interview – Dietmar Hopp glaubt an seine Biotechs – »Wir werden unseren Einsatz verdreifachen«".

Organisations Organisation Dievini Hopp BioTech Holding GmbH & Co. KG
  Group HOPP Group (family of Dietmar Hopp)
  Organisation 2 Heidelberg Pharma AG (FSE: WL6)
  Group Heidelberg Pharma (Group)
Products Product BIOTECH
  Product 2 venture capital
Index terms Index term Molecular Health–Hopp Group: investment, 201812 existent investment dievini Hopp owns 95% of Molecular Health GmbH
  Index term 2 Novaliq–Hopp Group: investment, 201812 existent investment dievini Hopp owns 93% of Novaliq GmbH
Persons Person Hopp, Dietmar (SAP)
  Person 2 von Bohlen, Friedrich (Dievini before Lion Bioscience)
     


   
Record changed: 2018-12-13

Advertisement

Picture Kentro Design Corporate and Web Design Berlin 650x65px

More documents for HOPP Group (family of Dietmar Hopp)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group Digital Medicine & Medtech Showcase 2021 at BTS2021 651x81




» top